Previous 10 | Next 10 |
home / stock / bmymp / bmymp news
The following slide deck was published by Bristol-Myers Squibb Company in conjunction with their 2021 Q1 earnings call. For further details see: Bristol-Myers Squibb Company 2021 Q1 - Results - Earnings Call Presentation
Bristol-Myers Squibb is currently enjoying a diversified asset portfolio whose sales are expected to keep growing going forward. The stock's valuation is hard to justify even when accounting for patent expirations potentially hurting revenues post-2025. The company is a free cash ...
Warning signals are flashing, suggesting it could be smart to fade the next move up. The strongest sectors currently include financials, REITs, and consumer goods. Over 100 highly-rated stocks across every major sector for your watch lists. For further details see: One L...
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. For further details see: Dividend Champion And Contender Highlights: Week Of April 25
In the past few years, the CAR-T, gene-based, regenerative medicines sector is becoming prominent. The premier logistic provider, Cryoport, is leading at the forefront of this innovation. When I first made my recommendation back in January 2018, Cryoport was trading at only $6.97....
AstraZeneca is a hyper-growth blue chip that expects a return to dividend growth in 2022. With one of the most promising drug pipelines in the industry, it could expand far faster than what it's enjoyed historically. In a world where hyper growth often trades at dangerous valuatio...
Recent immuno-oncology publications further confirm the Galectin Signature in cancer immunotherapy. In a rare and important combination of clinical effects, belapectin, Galectin's galectin-3 inhibitor, we believe can both augment ICI or immune agonist therapy while simultaneously impr...
The discount remains attractive on this fund that focuses on global positions. BOE's largest sector allocation is to tech, though not overwhelmingly so. This lower exposure to tech and focus on global positions, meant the fund's historical performance appeared lackluster - going f...
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...
An internationally weighted portfolio will inevitably have a dividend payout weighting favoring the months of March, April, and May (as well as November/October/September, usually). This is because many international/European stocks have annual or bi-annual payouts centered around mon...
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb $2Pr Company Name:
BMYMP Stock Symbol:
OTCMKTS Market:
Bristol-Myers Squibb $2Pr Website: